• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不表达百日咳毒素或百日咳黏附素的百日咳博德特氏菌分离株的首次报告及详细特征分析

First report and detailed characterization of B. pertussis isolates not expressing Pertussis Toxin or Pertactin.

作者信息

Bouchez V, Brun D, Cantinelli T, Dore G, Njamkepo E, Guiso N

机构信息

Institut Pasteur, Unité Prévention et Thérapie Moléculaires des Maladies Humaines, URA-CNRS 3012, 25 rue du Dr Roux, 75015 Paris, France.

出版信息

Vaccine. 2009 Oct 9;27(43):6034-41. doi: 10.1016/j.vaccine.2009.07.074. Epub 2009 Aug 8.

DOI:10.1016/j.vaccine.2009.07.074
PMID:19666155
Abstract

Bordetella pertussis isolates not expressing Pertussis Toxin (PT) or Pertactin (PRN) have been collected, for the first time in 2007, in France, a highly vaccinated country with acellular vaccines. Non-expression was due to deletion of the entire ptx locus, to IS481 insertion in the prn gene or deletion of a part of this gene. Genome sequencing does not indicate any regions of differences when compared to other circulating isolates. It nevertheless shows some sequence differences and an increased number of repeated sequences. The infant infected by the isolate not expressing pertussis toxin, did not present hyperlymphocytosis. All isolates were found less pathogen in animal or cellular models; their circulation raises the problem of clinical and biological diagnoses.

摘要

2007年,在法国这个高度接种无细胞疫苗的国家,首次收集到了不表达百日咳毒素(PT)或百日咳黏附素(PRN)的百日咳博德特氏菌分离株。不表达是由于整个ptx基因座缺失、IS481插入prn基因或该基因部分缺失所致。与其他流行的分离株相比,基因组测序未显示出任何差异区域。然而,它显示出一些序列差异和重复序列数量增加。感染不表达百日咳毒素分离株的婴儿未出现淋巴细胞增多症。在动物或细胞模型中发现所有分离株的致病性均较低;它们的传播引发了临床和生物学诊断方面的问题。

相似文献

1
First report and detailed characterization of B. pertussis isolates not expressing Pertussis Toxin or Pertactin.不表达百日咳毒素或百日咳黏附素的百日咳博德特氏菌分离株的首次报告及详细特征分析
Vaccine. 2009 Oct 9;27(43):6034-41. doi: 10.1016/j.vaccine.2009.07.074. Epub 2009 Aug 8.
2
Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia.澳大利亚百日咳杆菌缺乏百日咳毒素菌株迅速增加。
Emerg Infect Dis. 2014 Apr;20(4):626-33. doi: 10.3201/eid2004.131478.
3
Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains.疫苗株和临床百日咳博德特氏菌菌株的脉冲场凝胶电泳、丝状血凝素、百日咳毒素S1亚基多态性及表面组分析
Clin Vaccine Immunol. 2007 Nov;14(11):1490-8. doi: 10.1128/CVI.00177-07. Epub 2007 Aug 15.
4
Pertactin-negative Bordetella pertussis strains in Canada: characterization of a dozen isolates based on a survey of 224 samples collected in different parts of the country over the last 20 years.加拿大百日咳杆菌无百日咳杆菌粘附素菌株:基于对过去20年在该国不同地区收集的224份样本的调查,对12株分离株的特征分析
Int J Infect Dis. 2014 Nov;28:65-9. doi: 10.1016/j.ijid.2014.08.002. Epub 2014 Sep 22.
5
Bordetella pertussis Strain Lacking Pertactin and Pertussis Toxin.缺乏百日咳黏附素和百日咳毒素的百日咳博德特氏菌菌株
Emerg Infect Dis. 2016 Feb;22(2):319-322. doi: 10.3201/eid2202.151332.
6
Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years.在法国过去10年中流行的百日咳博德特氏菌分离株的多态性,该国使用单一有效的全细胞疫苗已有30多年。
J Clin Microbiol. 2001 Dec;39(12):4396-403. doi: 10.1128/JCM.39.12.4396-4403.2001.
7
Analysis of Bordetella pertussis pertactin and pertussis toxin types from Queensland, Australia, 1999-2003.1999 - 2003年澳大利亚昆士兰州百日咳博德特氏菌粘附素和百日咳毒素类型分析
BMC Infect Dis. 2006 Mar 16;6:53. doi: 10.1186/1471-2334-6-53.
8
Pertactin-negative Bordetella pertussis strains: evidence for a possible selective advantage.无荚膜百日咳博德特氏菌阴性菌株:可能具有选择优势的证据。
Clin Infect Dis. 2015 Jan 15;60(2):223-7. doi: 10.1093/cid/ciu788. Epub 2014 Oct 9.
9
Pertactin-deficient isolates: evidence of increased circulation in Europe, 1998 to 2015.无荚膜缺失株:1998 年至 2015 年在欧洲循环增加的证据。
Euro Surveill. 2019 Feb;24(7). doi: 10.2807/1560-7917.ES.2019.24.7.1700832.
10
Genetic Variation of Bordetella pertussis in Austria.奥地利百日咳博德特氏菌的基因变异
PLoS One. 2015 Jul 16;10(7):e0132623. doi: 10.1371/journal.pone.0132623. eCollection 2015.

引用本文的文献

1
exhibits genomic diversity within patients and laboratory culture.在患者体内和实验室培养环境中呈现出基因组多样性。
mSystems. 2025 Jul 22;10(7):e0171724. doi: 10.1128/msystems.01717-24. Epub 2025 Jun 17.
2
Learning the fitness dynamics of pathogens from phylogenies.从系统发育学中了解病原体的适应度动态。
Nature. 2025 Jan;637(8046):683-690. doi: 10.1038/s41586-024-08309-9. Epub 2025 Jan 1.
3
Resurgence of , including one macrolide-resistant isolate, France, 2024.法国 2024 年出现了 ,包括一个耐大环内酯的分离株。
Euro Surveill. 2024 Aug;29(31). doi: 10.2807/1560-7917.ES.2024.29.31.2400459.
4
Intranasal challenge with B. pertussis leads to more severe disease manifestations in mice than aerosol challenge.经鼻挑战百日咳博德特氏菌会导致小鼠出现比气溶胶挑战更严重的疾病表现。
PLoS One. 2023 Nov 2;18(11):e0286925. doi: 10.1371/journal.pone.0286925. eCollection 2023.
5
Vaccine Antigen Deficiency Does Not Substantially Affect the Identification of Bordetella pertussis Strains by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry.疫苗抗原缺乏对通过基质辅助激光解吸电离飞行时间质谱法鉴定百日咳博德特氏菌菌株的影响不大。
J Clin Microbiol. 2023 Apr 20;61(4):e0166522. doi: 10.1128/jcm.01665-22. Epub 2023 Mar 28.
6
Evaluation of Whole-Cell and Acellular Pertussis Vaccines in the Context of Long-Term Herd Immunity.在长期群体免疫背景下对全细胞百日咳疫苗和无细胞百日咳疫苗的评估。
Vaccines (Basel). 2022 Dec 20;11(1):1. doi: 10.3390/vaccines11010001.
7
Can vaccines control bacterial virulence and pathogenicity? : the advantage of fitness over virulence.疫苗能控制细菌的毒力和致病性吗?:适应性优于毒力的优势。
Evol Med Public Health. 2022 Aug 3;10(1):363-370. doi: 10.1093/emph/eoac028. eCollection 2022.
8
Pertactin-Deficient Bordetella pertussis with Unusual Mechanism of Pertactin Disruption, Spain, 1986-2018.1986-2018 年西班牙无 pertactin 缺陷百日咳博德特氏菌及其 pertactin 破坏的异常机制。
Emerg Infect Dis. 2022 May;28(5):967-976. doi: 10.3201/eid2805.211958.
9
Novel Strategies to Inhibit Pertussis Toxin.抑制百日咳毒素的新策略。
Toxins (Basel). 2022 Mar 3;14(3):187. doi: 10.3390/toxins14030187.
10
Pathogenicity and virulence of and its adaptation to its strictly human host.及对其严格人类宿主的适应能力的致病性和毒力。
Virulence. 2021 Dec;12(1):2608-2632. doi: 10.1080/21505594.2021.1980987.